Font Size: a A A

Intestinal Pathology And Gut Microbiota In A MPTP Mouse Model Of Parkinson's Disease

Posted on:2020-03-03Degree:MasterType:Thesis
Country:ChinaCandidate:F LaiFull Text:PDF
GTID:2404330590979790Subject:Health Inspection learning
Abstract/Summary:PDF Full Text Request
Objective: Patients with parkinson's disease(PD)often have non-motor symptoms related to gastrointestinal(GI)dysfunction,such as constipation and delayed gastric emptying,which manifest prior to the motor symptoms of PD.The exact pathogenesis of PD is unclear,and genetic factors,environmental factors,oxidative stress and other factors may be involved in the progress of PD.There is increasing evidence that changes in the composition of the gut microbiota may be related to the pathogenesis of PD.However,it is unclear how GI dysfunction occurs and how gut microbial dysbiosis is caused.Since GI dysfunction and the gut microbiota play important roles in PD,we investigated whether a neurotoxin model of PD induced by chronic low doses of MPTP is capable of reproducing the clinical pathological features of PD,as well as whether gut microbial dysbiosis accompanies this pathology.Methods: 40 C57BL/6 male mice,aged 10 weeks,were administered 18 mg/kg MPTP twice per week for 5 weeks via intraperitoneal injection.GI function was assessed by measuring the 1-hour stool frequency and fecal water content;motor function was assessed by pole tests;tyrosine hydroxylase(TH)and alpha-synuclein(?-syn)expression of substantia nigra(SN)and ileum were analyzed by western blotting(WB)and immunofluorescence(IF);the content of dopamine(DA)in striatum and ileum was measured by liquid chromatography-mass spectrometry(LC-MS);the inflammatory expression of SN was analyzed by IF and enzyme linked immunosorbent assay(ELISA);the inflammatory expression of ileum was analyzed by immunofluorescence(IHC)and ELISA;the expression of diamine oxidase(DAO)and d-lactic(D-LA)acid in the serum were measured by ELISA to evaluate the intestinal barrier damage;furthermore,the composition of the gut microbiota were measured by high-throughput sequencing.Results: We found that MPTP caused GI dysfunction and intestinal pathology prior to motor dysfunction;the expression of TH and ?-syn in SN and ileum of PD mice were changed;the content of DA in striatum and ileum of PD mice were decreased;MPTP induced inflammation in SN and ileum of mice;the expression of DAO and D-LA were increased,indicating the intestinal barrier had been impaired;the high-throughput sequencing result displayed the composition of the gut microbiota was changed;in particular,the change in the abundance of Lachnospiraceae,Erysipelotrichaceae,Prevotellaceae,Clostridiales,Erysipelotrichales and Proteobacteria was significant.Conclusion: These results indicate that a chronic low-dose MPTP model can be used to evaluate the progression of intestinal pathology and gut microbiota dysbiosis in the early stage of PD,which may provide new insights into the pathogenesis of PD and new ideas for the treatment of PD from the perspective of improving GI health.
Keywords/Search Tags:Parkinson's disease, MPTP, intestinal pathology, gut microbiota
PDF Full Text Request
Related items
Twice Subacute MPTP Administrations Induced Time-dependent Dopaminergic Neurodegeneration And Inflammation In Midbrain And Ileum,as Well As Gut Microbiota Disorders In PD Mice
Intragastric Administration Of Casein Leads To Nigrostriatal Disease Progressed Accompanied With Persistent Nigrostriatal-intestinal Inflammation Activited And Intestinal Microbiota-metabolic Disorders Induced In MPTP Mouse Model Of Parkinson's Disease
Neuroprotective Effect Of Ceftriaxone On MPTP Induced Parkinson's Disease Mice By Regulating Inflammation And Intestinal Microbiota
Effect And Mechanism Of Early Electroacupuncture Intervention On MPTP/MPP+-induced Mouse Model Of Parkinson's Disease
The Experimental Study Of PD-like Pathology And Abberant Intestinal Microbiota In The ?-syn+/-(A53T) Transgenic Mice Combined With Rotenone Treatment
The Neuroprotective Effect And Mechnasims Of Fecal Microbiota Transplantation On MPTP-induced Parkinson's Disease Model Of Mice
The Study On Gait Behavior Of MPTP-induced Subacute Parkinson's Mice Treated By Electroacupuncture And The Relationship With Intestinal Flora
Molecular Regulatory Mechanism Of Neurodegenerative Processes In MPTP/probenecid-induced Progressive Parkinson's Disease Mice Revealed By Transcriptome
The Experimental Investigation Of The Effect Of PDTC On The Expression Of NF-κB In Substantia Nigra Of Parkinson's Disease Mouse Model By MPTP
10 The Differential Research On Gut Microbiota Between Patients With Parkinson's Disease And Age-matched Controls In Northeast China